| Primary |
| Product Used For Unknown Indication |
16.7% |
| Schizophrenia |
13.3% |
| Anxiety |
8.3% |
| Rhinitis Allergic |
8.3% |
| Urticaria |
8.3% |
| Suicide Attempt |
6.7% |
| Dermatosis |
5.0% |
| Insomnia |
5.0% |
| Asthma |
3.3% |
| Eczema |
3.3% |
| Idiopathic Urticaria |
3.3% |
| Prurigo |
3.3% |
| Rash |
3.3% |
| Sleep Disorder |
3.3% |
| Antiallergic Therapy |
1.7% |
| Dyspnoea |
1.7% |
| Hypersensitivity |
1.7% |
| Postpartum Disorder |
1.7% |
| Skin Test |
1.7% |
|
| Completed Suicide |
30.6% |
| Respiratory Arrest |
16.3% |
| Urticaria |
6.1% |
| Cardiac Arrest |
4.1% |
| Charles Bonnet Syndrome |
4.1% |
| Condition Aggravated |
4.1% |
| Drug Screen False Positive |
4.1% |
| Psoriasis |
4.1% |
| Somnolence |
4.1% |
| Abnormal Behaviour |
2.0% |
| Anxiety |
2.0% |
| Coeliac Disease |
2.0% |
| Colitis |
2.0% |
| Confusional State |
2.0% |
| Death |
2.0% |
| Dizziness |
2.0% |
| Drug Abuse |
2.0% |
| Drug Dependence |
2.0% |
| Drug Eruption |
2.0% |
| Drug Hypersensitivity |
2.0% |
|
| Secondary |
| Product Used For Unknown Indication |
25.3% |
| Anxiety |
20.2% |
| Schizophrenia |
7.1% |
| Drug Use For Unknown Indication |
5.1% |
| Abdominal Pain Upper |
3.0% |
| Convulsion |
3.0% |
| Hyperhidrosis |
3.0% |
| Infection Prophylaxis |
3.0% |
| Insomnia |
3.0% |
| Myalgia |
3.0% |
| Pain |
3.0% |
| Psychotic Disorder |
3.0% |
| Rhinitis Allergic |
3.0% |
| Completed Suicide |
2.5% |
| Pruritus |
2.5% |
| Asthma |
2.0% |
| Depression |
2.0% |
| Gastroenteritis |
2.0% |
| Hypersensitivity |
2.0% |
| Idiopathic Urticaria |
2.0% |
|
| Completed Suicide |
18.5% |
| Toxicity To Various Agents |
18.5% |
| Respiratory Arrest |
16.0% |
| Drug Ineffective |
4.9% |
| Fatigue |
3.7% |
| Somnolence |
3.7% |
| Blood Pressure Fluctuation |
2.5% |
| Cardiac Arrest |
2.5% |
| Death |
2.5% |
| Erythema |
2.5% |
| Intentional Drug Misuse |
2.5% |
| Lip Oedema |
2.5% |
| Malaise |
2.5% |
| Nausea |
2.5% |
| Overdose |
2.5% |
| Pain |
2.5% |
| Pyrexia |
2.5% |
| Urticaria |
2.5% |
| Vertigo |
2.5% |
| Visual Acuity Reduced |
2.5% |
|
| Concomitant |
| Prophylaxis |
14.0% |
| Product Used For Unknown Indication |
12.9% |
| Premedication |
7.6% |
| Bone Marrow Conditioning Regimen |
7.4% |
| Drug Use For Unknown Indication |
5.8% |
| Anxiety |
5.3% |
| Infection Prophylaxis |
4.9% |
| Prophylaxis Against Graft Versus Host Disease |
4.9% |
| Antifungal Prophylaxis |
4.5% |
| Pain |
4.4% |
| Insomnia |
4.2% |
| Prophylaxis Of Nausea And Vomiting |
4.1% |
| Depression |
3.8% |
| Antiviral Prophylaxis |
3.3% |
| Aplastic Anaemia |
2.9% |
| Antibiotic Prophylaxis |
2.5% |
| Schizophrenia |
2.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.8% |
| Gastritis Prophylaxis |
1.8% |
| Sleep Disorder |
1.8% |
|
| Vomiting |
10.6% |
| Type 2 Diabetes Mellitus |
8.8% |
| Weight Increased |
8.8% |
| White Blood Cell Count Decreased |
6.9% |
| Williams Syndrome |
6.9% |
| Pyrexia |
6.3% |
| Urticaria |
5.6% |
| Pulmonary Embolism |
5.0% |
| Somnolence |
5.0% |
| Vision Blurred |
5.0% |
| Rash |
4.4% |
| Wound |
3.8% |
| Nausea |
3.1% |
| Renal Failure Acute |
3.1% |
| Suicide Attempt |
3.1% |
| Tremor |
3.1% |
| Tricuspid Valve Incompetence |
3.1% |
| Cytomegalovirus Infection |
2.5% |
| Disability |
2.5% |
| Dyspnoea |
2.5% |
|
| Interacting |
| Product Used For Unknown Indication |
28.6% |
| Anxiety |
19.0% |
| Hypertension |
9.5% |
| Musculoskeletal Chest Pain |
9.5% |
| Blood Cholesterol Abnormal |
4.8% |
| Bursitis |
4.8% |
| Cough |
4.8% |
| Fluid Retention |
4.8% |
| Heart Rate Irregular |
4.8% |
| Urticaria |
4.8% |
| Wheezing |
4.8% |
|
| Confusional State |
33.3% |
| Musculoskeletal Chest Pain |
33.3% |
| Somnolence |
33.3% |
|
